NICE to Recommend Eli Lilly’s Obesity Drug Mounjaro for NHS Use
The UK’s National Institute for Health and Care Excellence (NICE) announced on Thursday that it plans to recommend Eli Lilly’s obesity drug Mounjaro for use through...
The UK’s National Institute for Health and Care Excellence (NICE) announced on Thursday that it plans to recommend Eli Lilly’s obesity drug Mounjaro for use through...
Eli Lilly reported stellar second-quarter earnings, significantly exceeding market expectations, driven by robust sales of its diabetes drug Mounjaro and weight loss injection Zepbound. The pharmaceutical...
All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to the latest update...